In Japan, the number of patients who undergo RAI therapy has been increasing annually, and the demand is increasing. However, the reality is that the number of operational beds has decreased. Thus, it is impossible to aggressively perform ablation after total thyroidectomy and the waiting time for RAI therapy is prolonged. However, the situation for RAI therapy is expected to improve with the availability of ablation using up to 30 mCi of RAI at outpatient clinics, which is soon to be approved.
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428 (RS)PubMedCrossRefGoogle Scholar
Mazzaferri EL, Kloos RT (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463 (NR)PubMedCrossRefGoogle Scholar
Robbins RJ, Schlumberger MJ (2005) The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med 46(Suppl 1):28S–37S (NR)PubMedGoogle Scholar
Sawka AM, Thephamongkhol K, Brouwers M et al (2004) Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668–3676 (SR<RS>)PubMedCrossRefGoogle Scholar
Yokoyama K, Kinutani K, Michigishi T et al (2006) (Text in Japanese) Geka 68:773–776 (NR)Google Scholar
Shibuya H, Sugino K, Nagahama M et al (2007) (Text in Japanese) Rinsho Hoshasen 52:847–854 (RS)Google Scholar
Kusakabe K (2006) (Text in Japanese) Horumon to Rinsho 54:113–116 (NR)Google Scholar
Hackshaw A, Harmer C, Mallick U et al (2007) 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin Endocrinol Metab 92:28–38 (SR<RS>)PubMedCrossRefGoogle Scholar